The table below shows Krystal Biotech, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$389.13M
$290.51M
$50.70M
$0.00
$0.00
-
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$58.05M
$53.58M
$46.43M
$42.46M
$27.88M
$17.94M
SG&A
$146.74M
KRYS annual revenue (10-K history)
Krystal Biotech, Inc. reported annual revenue of $389.13M for fiscal year 2025. That is up 33.9% from $290.51M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
